Преглед
Промяна на цената на акция
24 ч
Текуща
Минимум
144.71
Максимум
151.36
Приходи | -6.1M -22M |
|---|---|
Служители | 29 |
EBITDA | -5.8M -20M |
Препоръки | Силна покупка |
|---|---|
12-месечна прогноза | +58.57% upside |
Следващи печалби | 5.11.2026 г. |
|---|
Пазарна капитализация | -129M 1.6B |
|---|---|
Предишно отваряне | 151.09 |
Предишно затваряне | 145.22 |
Palvella Therapeutics Inc Графика
Миналото представяне не гарантира бъдещи резултати.
Свързани новини
30.10.2026 г., 23:51 ч. UTC
FMC Corp shares are declining in after-market hours following disappointing Q3 earnings, with an 80% revenue drop to $106 million and an adjusted loss per share of $4.41.
Прочетени
30.10.2026 г., 23:51 ч. UTC
BTIG suspended its Buy rating on Zoetis Inc, contributing to a modest decline in the stock during after-market hours.
Прочетени
30.10.2026 г., 23:51 ч. UTC
Stryker receives mixed analyst assessments, with Stifel lowering its price target to $325 and Citigroup adjusting to $315, both maintaining Buy ratings.
Прочетени
30.10.2026 г., 23:41 ч. UTC
Allegro Microsystems Inc. reported Q2 FY27 sales of $276.88M, exceeding expectations, and provided Q3 guidance of $278M to $288M, with shares modestly higher in after-market trading.
Прочетени
30.10.2026 г., 23:41 ч. UTC
BTIG suspended its Buy rating on IDEXX Laboratories, contributing to a decline in the stock's price during after-market hours.
Прочетени
30.10.2026 г., 23:36 ч. UTC
Capri Holdings Ltd reported Q2 profit of 42 cents per share and raised full-year EPS forecast to $2.20, with shares trading lower in after-market hours.
Прочетени
30.10.2026 г., 23:31 ч. UTC
McGrath RentCorp will replace Glaukos in the S&P 600 index at the market open on November 4, 2026, contributing to positive after-market price movement.
Прочетени
30.10.2026 г., 23:26 ч. UTC
JP Morgan maintains its Underweight rating on T. Rowe Price while raising the price target to $107; TD Cowen lowers its target to $96.
Прочетени
30.10.2026 г., 23:26 ч. UTC
Citigroup reaffirms Buy rating on Fortrea Holdings Inc and raises price target to $27, according to a report published today.
Прочетени
30.10.2026 г., 23:21 ч. UTC
Compass Inc. faces a class action lawsuit from Pomerantz LLP, alleging securities fraud related to its merger with Anywhere Real Estate Inc.
Прочетени
30.10.2026 г., 23:16 ч. UTC
JP Morgan maintains Neutral rating on Dexcom Inc and raises its price target to $85, reflecting the company's market position and growth potential.
Прочетени
30.10.2026 г., 23:11 ч. UTC
Pomerantz LLP has filed a class action lawsuit against The Chemours Company, alleging misleading statements and violations of federal securities laws.
Прочетени
30.10.2026 г., 23:11 ч. UTC
Cantor Fitzgerald identifies Binance's $6.3 billion hack as a potential buying opportunity for crypto-linked stocks, including Strategy Inc., amid recovery confidence.
Прочетени
30.10.2026 г., 23:06 ч. UTC
Uranium Energy Corp. shares declined in after-market hours, reflecting broader sector pressures despite analysts noting tightening supply in the uranium market.
Прочетени
30.10.2026 г., 23:06 ч. UTC
S&P Global Ratings revised its outlook on Meta Platforms, Inc. to negative, citing uncertainty over capital expenditures and projected free operating cash flow deficits.
Прочетени
30.10.2026 г., 23:06 ч. UTC
eBay expands managed shipping program amid seller eligibility concerns.
Прочетени
30.10.2026 г., 23:06 ч. UTC
Coinbase Global, Inc. received an Overweight rating from JP Morgan, which lowered its price target to $187 amid security concerns following the $6.3 billion Binance hack.
Прочетени
30.10.2026 г., 23:06 ч. UTC
Starbucks plans to trial an AI-driven "fast pass" feature for drive-throughs to enhance customer experience, leveraging its app and loyalty program.
Прочетени
30.10.2026 г., 23:06 ч. UTC
Kraft Heinz Company shares are trading modestly higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month range.
Прочетени
30.10.2026 г., 23:06 ч. UTC
The Hershey Company is trading higher in after-market hours, following analysts' adjustments with Evercore ISI lowering its price target to $200 and TD Cowen maintaining $198.
Прочетени
30.10.2026 г., 23:06 ч. UTC
DraftKings Inc. shares declined in after-market trading, pulling back from earlier gains as investors anticipate an upcoming earnings report amid ongoing pressure.
Прочетени
30.10.2026 г., 23:06 ч. UTC
Celsius Holdings faces a class action lawsuit from Pomerantz LLP over alleged federal securities law violations related to its Alani Nu energy drinks' marketing practices.
Прочетени
30.10.2026 г., 23:06 ч. UTC
Citigroup maintains a Neutral rating on Enphase Energy and lowers its price target to $25, which may have influenced investor sentiment.
Прочетени
30.10.2026 г., 23:06 ч. UTC
Ares Capital Corp announces a merger agreement to acquire MidCap Financial Investment Corporation, leading to the cancellation of MidCap's earnings call on November 5, 2026.
Прочетени
30.10.2026 г., 23:02 ч. UTC
Bitcoin has declined below $77K following a significant security breach at Binance, resulting in the theft of approximately $6.3 billion and raising cybersecurity concerns.
Прочетени
30.10.2026 г., 23:01 ч. UTC
Dyadic International Inc will report its Q3 2026 financial results and host a conference call on November 12, 2026, to enhance investor transparency.
Прочетени
30.10.2026 г., 23:01 ч. UTC
Rivian Automotive reported Q3 revenue of $2.15 billion and raised full-year delivery guidance to 67k units, despite shares falling in after-market trading.
Прочетени
30.10.2026 г., 23:01 ч. UTC
BWX Technologies Inc. is rising in after-market trading after being selected by the U.S. Army for a $2.2 billion nuclear microreactor project.
Прочетени
30.10.2026 г., 23:01 ч. UTC
JP Morgan maintains Neutral rating on Republic Services and raises price target to $265, following an update published after the market close.
Прочетени
30.10.2026 г., 23:01 ч. UTC
Twilio Inc. is under investigation by Levi & Korsinsky for potential federal securities law violations related to its lowered Q4 revenue growth guidance.
Прочетени
Сравнение с други в отрасъла
Ценова промяна
Palvella Therapeutics Inc Прогноза
Ценова цел
By TipRanks
12-месечна прогноза
Среден 231.75 USD 58.57%
Висок 267 USD
Нисък 207 USD
Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за Palvella Therapeutics Inc през последните три месеца.
Консенсусна оценка
By TipRanks
Силна покупка
13 ratings
13
Купи
0
Задържане
0
Продай
Според 13 анализатори, дали борсови рейтинги на Palvella Therapeutics Inc през последните 3 месеца.
Финанси
Продажбени и админисративни разходи
Печалба преди облагане с данъци
Продажби
Разходи за лихви по дълг
EBITDA
Оперативна печалба
$